Jubilant Generics Limited — Irbesartan Exporter Profile
Indian Pharmaceutical Exporter · #11 for Irbesartan · $1.3M export value · DGFT Verified
Jubilant Generics Limited is the #11 Indian exporter of Irbesartan with $1.3M in export value and 84 verified shipments. Jubilant Generics Limited holds a 1.2% market share in Irbesartan exports across 7 countries. The company exports 6 pharmaceutical products worth $23.9M across 4 therapeutic categories.
Jubilant Generics Limited — Irbesartan Export Profile: Buyers & Destinations
Where Does Jubilant Generics Limited Export Irbesartan?
| Country | Value | Shipments | Share |
|---|---|---|---|
| SOUTH AFRICA | $300.8K | 15 | 24.4% |
| UNITED KINGDOM | $224.8K | 11 | 18.3% |
| CANADA | $224.2K | 41 | 18.2% |
| BELGIUM | $212.7K | 10 | 17.3% |
| UNITED STATES | $138.3K | 6 | 11.2% |
| HONG KONG | $123.4K | 4 | 10.0% |
| TANZANIA | $6.2K | 1 | 0.5% |
| CROATIA | $13 | 3 | 0.0% |
Jubilant Generics Limited exports Irbesartan to 8 countries. The largest destination is SOUTH AFRICA accounting for 24.4% of Jubilant Generics Limited's Irbesartan shipments, followed by UNITED KINGDOM (18.3%) and CANADA (18.2%). These destinations reflect Jubilant Generics Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Irbesartan from Jubilant Generics Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| YUSEN LOGISTICS BENELUX | BELGIUM | $192.6K | 7 |
| JUBILANT PHARMA SA (PTY) LIMITED | SOUTH AFRICA | $191.7K | 10 |
| ELARA PHARMASERVICES LIMITED | UNITED KINGDOM | $161.0K | 9 |
| JUBILANT CADISTA PHARMACEUTICALS | UNITED STATES | $138.3K | 6 |
| WILLIAMS PHARMALOGISTIQUE INC | CANADA | $137.3K | 25 |
| CONTROLLED MEDICATIONS LTD | HONG KONG | $123.4K | 4 |
| JUBILANT PHARMA SA PTY LIMITED | SOUTH AFRICA | $109.1K | 5 |
| LABORATOIRE RIVA INC | CANADA | $86.9K | 16 |
| ELARA PHARMA SERVICES LIMITED | UNITED KINGDOM | $63.7K | 2 |
| YUSEN LOGISTICS BANELUX | BELGIUM | $20.2K | 3 |
Jubilant Generics Limited supplies Irbesartan to 12 buyers globally. The largest buyer is YUSEN LOGISTICS BENELUX (BELGIUM), followed by JUBILANT PHARMA SA (PTY) LIMITED (SOUTH AFRICA) and ELARA PHARMASERVICES LIMITED (UNITED KINGDOM). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Irbesartan Export Value and How Much Does Jubilant Generics Limited Contribute?
India exported $58.2M worth of Irbesartan through 2,669 shipments from 123 suppliers to 68 countries, serving 366 buyers globally. Jubilant Generics Limited contributes $1.3M to this total, accounting for 1.2% of India's Irbesartan exports. Jubilant Generics Limited ships Irbesartan to 8 countries through 12 buyers.
What Is the Average Shipment Value for Jubilant Generics Limited's Irbesartan Exports?
Jubilant Generics Limited's average Irbesartan shipment value is $15.1K per consignment, based on 84 shipments totaling $1.3M. The largest destination is SOUTH AFRICA (24.4% of Jubilant Generics Limited's Irbesartan exports).
How Does Jubilant Generics Limited Compare to Other Indian Irbesartan Exporters?
Jubilant Generics Limited ranks #11 among 123 Indian Irbesartan exporters with a 1.2% market share. The top 3 exporters are MYLAN LABORATORIES LIMITED ($10.8M), MACLEODS PHARMACEUTICALS LTD ($8.9M), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($8.3M). Jubilant Generics Limited processed 84 shipments to 7 destination countries.
What Irbesartan Formulations Does Jubilant Generics Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| JUBITAN 300MG (IRBESARTAN FCT TABLET) 2x | $100.0K | 2 |
| IRBESARTAN 300MG FCT 2X14 JUB, BATCH-IR3 | $100.0K | 2 |
| IRBESARTAN USP 300 MG BT 90 CADI | $50.0K | 1 |
| IRBESARTAN USP 150 MG BT 90 CADI | $50.0K | 1 |
| Irbesartan 300mg FCT 2x14 Jub UK Elara,BATCH NO. IR325003A, MFG. DT. 01.12.2024, EXP. DT. 30.11.2027 | $50.0K | 1 |
| IRBESARTAN 300 MG FCT 2X 14 JUB UK ELARA, BATCH IR325002A MFG 01.12.2024, EXP 30.11.2027 | $50.0K | 1 |
| IRBESARTAN 300 MG FCT 2X 14 JUB UK ELARA, BATCH IR325001A MFG 01.12.2024, EXP 30.11.2027 | $49.9K | 1 |
| Irbesartan 150mg FCT 2x14 Jub,Batch-IR22 | $37.5K | 1 |
| IRBESARTAN 150MG TAB 2X14 SWED, BATCH NO | $33.3K | 1 |
| IRBESARTAN 150MG TAB 2X14,B.NO.IR223005A, MANUFACTURING :12.08.2023,EXP:31.07.2025 | $32.9K | 1 |
Jubilant Generics Limited exports 80 distinct Irbesartan formulations including tablets, capsules, syrups, and combination drugs. The top formulation is JUBITAN 300MG (IRBESARTAN FCT TABLET) 2x with 2 shipments worth $100.0K.
Regulatory Requirements: Exporting Irbesartan to Key Markets
What Jubilant Generics Limited must comply with to export Irbesartan to its top destination countries
South Africa — SAHPRA
Approval Process
Registration under SAHPRA guidelines (CTD format). Bioequivalence required for generics.
Timeline: 24–48 months (significant backlog)
GMP & Export Requirements
WHO GMP or PIC/S GMP compliance
Certificate of Pharmaceutical Product from CDSCO; Import permit per Section 22A of Medicines Act
Note: Known registration backlog. WHO Prequalification significantly assists the process.
United Kingdom — MHRA
Approval Process
Post-Brexit UK Marketing Authorisation via national procedure. Separate from EU approval since January 2021.
Timeline: 12–15 months
GMP & Export Requirements
UK GMP compliance; MHRA inspection of manufacturing site
Manufacturer Import Authorisation (MIA) held by UK importer; Qualified Person (QP) batch release
Note: Post-Brexit: EU GMP certificates no longer automatically valid in UK. Separate MHRA recognition required.
Canada — HC
Approval Process
ANDS (Abbreviated New Drug Submission) referencing Canadian Reference Product. Comparative bioavailability study required.
Timeline: 12–18 months
GMP & Export Requirements
Health Canada GMP (GUI-0001); Drug Establishment Licence (DEL) inspection
Drug Identification Number (DIN) for each product; Certificate of Pharmaceutical Product from CDSCO
Note: Subject to Good Import Practices and annual C.01.014.6 review.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Jubilant Generics Limited Compare to Nearest Irbesartan Exporters?
Exporters ranked immediately above and below #11 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 8 | ZYDUS LIFESCIENCES LIMITED | $2.4M | 162 | 6 | $15.1K |
| 9 | INTAS PHARMACEUTICALS LIMITED | $1.8M | 156 | 5 | $11.5K |
| 11 | JUBILANT GENERICS LIMITED ★ | $1.3M | 84 | 7 | $15.1K |
| 12 | MICRO LABS LIMITED | $1.3M | 41 | 6 | $30.8K |
| 13 | AUROBINDO PHARMA LIMITED | $1.2M | 109 | 3 | $11.2K |
Jubilant Generics Limited ranks #11 among 123 Indian Irbesartan exporters. Average shipment value of $15.1K compared to the market average of $473.0K. The closest competitors by value are ZYDUS LIFESCIENCES LIMITED and INTAS PHARMACEUTICALS LIMITED.
Which Indian Ports Ship Irbesartan Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 284 | 10.6% |
| SAHAR AIR | 197 | 7.4% |
| SAHAR AIR CARGO ACC (INBOM4) | 170 | 6.4% |
| JNPT/ NHAVA SHEVA SEA | 147 | 5.5% |
| DELHI AIR | 135 | 5.1% |
| DELHI AIR CARGO ACC (INDEL4) | 133 | 5.0% |
| JNPT | 129 | 4.8% |
| MUNDRA SEA (INMUN1) | 108 | 4.0% |
What Other Cardiovascular Products Does Jubilant Generics Limited Export?
Jubilant Generics Limited also exports these cardiovascular products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Jubilant Generics Limited's Irbesartan Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Jubilant Generics. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, causing increased freight charges and potential losses estimated between ₹2,500 crore to ₹5,000 crore in March 2026. These disruptions have particularly impacted exports to the Middle East, a key market for Indian pharmaceuticals. (fortuneindia.com)
Conversely, U.S.-China trade tensions have opened avenues for Indian exporters to capture a larger share of the U.S. market. However, recent U.S. tariffs on imports, including pharmaceuticals, pose a risk to this opportunity. The Federation of Indian Export Organisations highlighted that these tariffs could affect nearly 55% of India's exports to the U.S., potentially leading to the loss of longstanding clients. (apnews.com)
In the European Union, compliance with the Falsified Medicines Directive (FMD) remains a critical requirement. Indian exporters must invest in serialization and traceability systems to meet these stringent regulations, ensuring continued access to the EU market.
Jubilant Generics Limited — Regulatory Compliance & Quality Standards
Maintaining compliance with international regulatory standards is paramount for Jubilant Generics. The company's Roorkee facility's VAI classification by the USFDA in 2024 reflects its adherence to current good manufacturing practices. (business-standard.com) However, the Indian pharmaceutical industry faces ongoing scrutiny regarding quality and compliance. In 2023, the USFDA conducted over 200 inspections in India, with plans to increase this number in 2024, underscoring the need for continuous quality assurance. (fact.net.in)
Additionally, the company has faced legal challenges concerning intellectual property. In March 2025, a court in Uttar Pradesh restrained Jamp Pharma from using Jubilant Generics' confidential data, granting an injunction against copyright infringement. (scconline.com) This case highlights the importance of safeguarding proprietary information in the competitive pharmaceutical landscape.
About Jubilant Generics Limited
Jubilant Generics Limited exports 6 products worth $23.9M. Beyond Irbesartan, top products include Azithromycin, Atorvastatin, Esomeprazole, Valsartan, Valacyclovir. View the complete Jubilant Generics Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Irbesartan — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Irbesartan shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Jubilant Generics Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 91 individual customs records matching Jubilant Generics Limited exporting Irbesartan, covering 80 formulations to 8 countries via 12 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 68+ countries, 366+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Irbesartan Export Data from Jubilant Generics Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Jubilant Generics Limited's Irbesartan exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Jubilant Generics Limited
Full Company Profile →
6 products · $23.9M total trade · 4 categories
Irbesartan Stats
Company Overview
Top Products by Jubilant Generics Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Jubilant Generics Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Irbesartan. For current shipment-level data, contact TransData Nexus.